ARS Pharmaceuticals SPRY
NASDAQ SPRY
$3.83 +0.26 (+7.28%)
As of: Nov 11, 2026 · 2:46 PM EST

ARS Pharmaceuticals (SPRY) Price to Earnings (2022 - 2024)

Updated

ARS Pharmaceuticals' Price to Earnings came in at 129.21 for Q4 2024.

Analysis

ARS Pharmaceuticals (SPRY) Price to Earnings (2022 - 2024) Analysis & Trends

  • The Q4 2024 figure represents the lowest quarterly Price to Earnings since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 ARS Pharmaceuticals 357.89 Mn 219.49 Mn 27.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 129.21
Sep 30, 2022 7.41
Jun 30, 2022 15.78
API Access

ARS Pharmaceuticals Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=SPRY&period=max&api_key=YOUR_API_KEY